BioRelix's Series B Round

BioRelix raised a round of funding on September 02, 2011.

BioRelix is discovering and developing new treatments for infectious diseases that target RiboSwitches, a class of RNA drug targets found in pathogenic bacteria and fungi. Riboswitches are short stret…

Articles about BioRelix's Series B Round: